Claritev Corporation (CTEV)
NYSE · Healthcare · Health Information Services
$24.68+4.05%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $418M
- Forward P/E
- 3.4
- 52-week range
- $11.50 – $73.68
- 52-week change
- −55.64%
- EPS (trailing)
- −$17.00
- Analyst rating
- 1.8 Buy
- Next earnings
- Nov 5, 2026
Fiscal year to Dec 2025
- Revenue
- $965M (+3.74%)
- Net income
- −$284M
- Operating margin
- 3.0%
- Diluted EPS
- −$17.30
- Free cash flow
- −$12.3M
From the company’s annual report on SEC EDGAR.
About Claritev Corporation
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators.
Headquarters: McLean, United States · 3,000 employees · claritev.com